Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-beta-susceptible hepatocellular carcinoma cells
Publication in refereed journal

Times Cited
Web of Science14WOS source URL (as at 15/09/2021) Click here for the latest count
Altmetrics Information

Other information
AbstractAIM: To investigate the role of transforming growth factor (TGF)-beta-inducible early gene 1 (TIEG1) in TGF-beta-induced growth inhibition in hepatocellular carcinoma (HCC) cells.
All Author(s) ListJiang L, Lai YK, Zhang JF, Chan CY, Lu G, Lin MCM, He ML, Li JC, Kung HF
Journal nameWorld Journal of Gastroenterology
Detailed descriptionTo ORKTS: doi: 10.3748/wjg.v18.i17.2035
Volume Number18
Issue Number17
PublisherW J G PRESS
Pages2035 - 2042
LanguagesEnglish-United Kingdom
KeywordsGrowth inhibition; Hepatocellular carcinoma; Stathmin; Transforming growth factor-beta; Transforming growth factor-beta-inducible early gene 1
Web of Science Subject CategoriesGastroenterology & Hepatology; GASTROENTEROLOGY & HEPATOLOGY

Last updated on 2021-16-09 at 00:55